108 related articles for article (PubMed ID: 3478733)
1. Clinical relevance of the CA-125 assay for the management of patients with ovarian carcinoma.
Raju RN; Dalbow MH; Pugh RP; Concannon JP; Zidar BL; Zamerilla CF; Schenken LL
Prog Clin Biol Res; 1987; 248():289-97. PubMed ID: 3478733
[No Abstract] [Full Text] [Related]
2. [Mucinous carcinoma-associated antigen (MCA) in ovarian cancer].
Hanzal E; Kölbl H; Gitsch G; Bieglmayer C
Gynakol Rundsch; 1990; 30 Suppl 1():68-70. PubMed ID: 2079303
[No Abstract] [Full Text] [Related]
3. [Clinical significance of the tumor marker CA-125 for the preoperative diagnosis and postoperative management of patients with malignant ovarian cancers].
Sevelda P; Salzer H; Dittrich C; Spona J
Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):769-73. PubMed ID: 3865860
[TBL] [Abstract][Full Text] [Related]
4. [Possibilities and limits of the study of tumor markers in the after-care of patients with ovarian cancer].
Kreienberg R
Gynakologe; 1986 Sep; 19(3):178-85. PubMed ID: 3770529
[No Abstract] [Full Text] [Related]
5. [Diagnosis of the recurrence of epithelial ovarian cancer with the tumor marker CA 125].
Sevelda P; Wagner G
Wien Klin Wochenschr; 1987 Nov; 99(21):768-70. PubMed ID: 3480655
[TBL] [Abstract][Full Text] [Related]
6. [Does follow-up of false-negative CA-125 serum values in tumor after-care of ovarian cancer make sense?].
Sevelda P; Rosen A; Barrada M; Gober S; Vavra N; Salzer H
Gynakol Rundsch; 1990; 30 Suppl 1():210-1. PubMed ID: 2079273
[No Abstract] [Full Text] [Related]
7. CA 125 as a marker in epithelial ovarian cancer: Alone and in comparison with CEA.
Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH; Balar DB; Patel TB
Indian J Cancer; 1987 Dec; 24(4):222-31. PubMed ID: 3505511
[No Abstract] [Full Text] [Related]
8. [The pre- and postoperative and follow-up use of the tumor markers MCA, CA-125 and CA-19-9].
Zanon C; Alluminio P; Margarita V; Sottimano C; Giuliani F; Neri G; Ballario F
Minerva Chir; 1992 Jan; 47(1-2):27-30. PubMed ID: 1553049
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of CA.125 as a co-adjuvant test in the diagnosis and follow-up of ovarian cancer].
Hernández Briz MJ; Díaz Redondo A; Mújica Menéndez I; Merino Ramírez J; Crespo Azanza E; Fernández Villoria E; Sánchez Martín JA
Rev Clin Esp; 1986 Oct; 179(5):240-2. PubMed ID: 3466260
[No Abstract] [Full Text] [Related]
10. [Pre- and post-therapeutic serum concentrations of mucin-like carcinoma-associated antigen in patients with breast cancer].
Fuith LC; Artner-Dworzak E; Schröcksnadel H; Müller-Holzner E; Daxenbichler G; Heim K
Gynakol Rundsch; 1989; 29 Suppl 2():397-9. PubMed ID: 2613061
[No Abstract] [Full Text] [Related]
11. [Serum level of the tumor marker CA 125 in ovarian pathology].
Bagni B; Pansini FS; Feggi LM; Prandini N; Mollica G
Radiol Med; 1987 Nov; 74(5):448-50. PubMed ID: 3479814
[TBL] [Abstract][Full Text] [Related]
12. [CA 125--a new characteristic in the diagnosis of ovarian carcinoma].
Tosner J
Cesk Gynekol; 1987 Jun; 52(5):381-5. PubMed ID: 3477330
[No Abstract] [Full Text] [Related]
13. Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.
Patsner B; Mann WJ; Chalas E
Obstet Gynecol; 1988 Jun; 71(6 Pt 1):949-50. PubMed ID: 3163416
[No Abstract] [Full Text] [Related]
14. [Incidence of CA 125 antigen in the blood of women with ovarian carcinoma].
Tosner J; Lacinová V; Louda B; Vanásek J
Cesk Gynekol; 1987 Nov; 52(9):681-4. PubMed ID: 3482173
[No Abstract] [Full Text] [Related]
15. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
Crombach G; Zippel HH; Würz H
Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
[TBL] [Abstract][Full Text] [Related]
16. Potential usefulness of monoclonal antibodies in invasive ovarian adenocarcinoma.
Patsner B; Day TG; Rao CV
J Ky Med Assoc; 1986 Nov; 84(11):613-5. PubMed ID: 3466996
[No Abstract] [Full Text] [Related]
17. [Ovarian carcinoma antigen (CA 125) and ovarian cancer (clinical follow-up and prognostic studies)].
Göcze P; Vahrson H
Orv Hetil; 1993 Apr; 134(17):915-8. PubMed ID: 8479736
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of new three tumor markers for pancreatic carcinoma: CA19/9, CA 125 and DuPan 2].
Ohkura H; Sakawaki T
Gan No Rinsho; 1985 May; 31(6 Suppl):583-8. PubMed ID: 3861882
[TBL] [Abstract][Full Text] [Related]
19. [Serum levels of the CA-125 antigen in the diagnosis of ovarian neoplasms].
Sopracordevole F; Finco B; Scarabelli C; Campagnutta E; Alimena C; Perin A
Minerva Ginecol; 1985 Oct; 37(10):589-96. PubMed ID: 3866146
[No Abstract] [Full Text] [Related]
20. [Clinical evaluation of a cancer antigen, CA 125, associated with ovarian cancer. I. Technical investigation and the reference value].
Sakurabayashi I; Kawai T; Suzuki M; Tamada T; Sato K; Yonezawa M
Rinsho Byori; 1984 Dec; 32(12):1345-9. PubMed ID: 6597875
[No Abstract] [Full Text] [Related]
[Next] [New Search]
